Abstract
This chapter provides an overview of how generic topical ophthalmic drug products are approved in the USA. Standards for approval of generic ophthalmic drug products and the role of the Office of Generic Drugs in review of generic ophthalmic drug products are explained. Equivalence evaluation of solution and non-solution topical ophthalmic dosage forms is described, and future research needed to advance equivalence standards are presented.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
